Albireo pharma, inc. reports earnings results for the third quarter ended september 30, 2019

Albireo pharma, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced sales was usd 1.385 million compared to usd 237,000 a year ago. operating loss was usd 20.636 million compared to usd 12.665 million a year ago. net loss was usd 21.910 million compared to usd 14.025 million a year ago. basic loss per share was usd 1.73 compared to usd 1.17 a year ago. for the nine months, sales was usd 3.205 million compared to usd 12.169 million a year ago. operating loss was usd 51.261 million compared to usd 23.652 million a year ago. net loss was usd 55.195 million compared to usd 30.247 million a year ago. basic loss per share was usd 4.47 compared to usd 2.6 a year ago.
ALBO Ratings Summary
ALBO Quant Ranking